History of haemophilia |
| |
| Authors: | L. M. ALEDORT |
| |
| Affiliation: | Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY, USA |
| |
| Abstract: | Summary. Haemophilia, an ancient disease, now has sophisticated methods for diagnosis and treatment. The genetically missing factors can now be supplied by fractionation of human-derived (HD) plasma or with recombinant technology (r). Making therapeutic choices is complicated by past transfusion-transmitted diseases. HD and r products now have similar safety profiles. Several diseases have only HD products for treatment. These products remain important in our treatment armamentarium. |
| |
| Keywords: | haemophilia inhibitors recombinant and human-derived factors Von Willebrand disease |
|
|
